High-risk patient factors include active gastrointestinal symptoms (odds ratio 7.66, 95% confidence interval 3.4217.17), early treatment phase (less than 4 weeks), higher medication doses, pre-existing diabetic gastroparesis, obesity (BMI greater than 30), and gastroesophageal reflux disease [31]
Attempting to change the color of your eyeball poses significant health risks such as infection, inflammation, or even vision loss
ICPEMC Working Paper 7/1/2
Its worth noting that a GLP1 pill (Rybelsus) containing a much lower dose of semaglutide the same active ingredient as Wegovy has been approved by the FDA since 2019 to treat type 2 diabetes
Hyperpigmentation: By inhibiting MMPs and ROS, it may lighten age spots and UV- induced discoloration